LabCorp to Announce Third Quarter Financial Results on October 24, 2018
September 25 2018 - 8:45AM
Business Wire
LabCorp® (NYSE: LH) will release its third quarter 2018
financial results before the market opens on Wednesday, October 24,
2018, and then will host a conference call and webcast beginning at
9:00 a.m. EDT to discuss the results. The earnings release and
accompanying financial information will be posted on the LabCorp
Investor Relations website.
Interested parties can access the conference call in listen-only
mode by dialing 844-634-1444 within the U.S. and Canada, or
1-615-247-0253 internationally, using the passcode 7398818. In
addition, a real-time webcast of the conference call will be
available on the LabCorp Investor Relations website.
An audio replay of the conference call will be available from
1:00 p.m. EDT on October 24, 2018, until 11:30 a.m. EDT on November
7, 2018, by dialing 855-859-2056 within the U.S. and Canada, or
1-404-537-3406 internationally, using the passcode 7398818. The
webcast of the conference call will be archived and accessible
through October 18, 2019, on the LabCorp Investor Relations
website.
About LabCorp
LabCorp (NYSE: LH), an S&P 500 company, is a leading global
life sciences company that is deeply integrated in guiding patient
care, providing comprehensive clinical laboratory and end-to-end
drug development services. With a mission to improve health and
improve lives, LabCorp delivers world-class diagnostic solutions,
brings innovative medicines to patients faster and uses technology
to improve the delivery of care. LabCorp reported net revenues of
more than $10 billion for 2017. To learn more about LabCorp, visit
www.labcorp.com, and to learn more about Covance Drug Development,
visit www.covance.com.
This press release contains forward-looking statements including
but not limited to statements with respect to estimated 2018
guidance and the related assumptions, the impact of various factors
on operating and financial results, expected savings and synergies
(including from the LaunchPad initiative and from acquisitions),
and the opportunities for future growth. Each of the
forward-looking statements is subject to change based on various
important factors, including without limitation, competitive
actions and other unforeseen changes and general uncertainties in
the marketplace, changes in government regulations, including
healthcare reform, customer purchasing decisions, including changes
in payer regulations or policies, other adverse actions of
governmental and third-party payers, changes in testing guidelines
or recommendations, adverse results in material litigation matters,
the impact of changes in tax laws and regulations, failure to
maintain or develop customer relationships, our ability to develop
or acquire new products and adapt to technological changes, failure
in information technology, systems or data security, employee
relations, and the effect of exchange rate fluctuations. Actual
results could differ materially from those suggested by these
forward-looking statements. The Company has no obligation to
provide any updates to these forward-looking statements even if its
expectations change. Further information on potential factors,
risks and uncertainties that could affect operating and financial
results is included in the Company’s Form 10-K for the year ended
December 31, 2017, and subsequent Forms 10-Q, including in each
case under the heading risk factors, and in the Company’s other
filings with the SEC. The information in this press release should
be read in conjunction with a review of the Company’s filings with
the SEC including the information in the Company’s Form 10-K for
the year ended December 31, 2017, and subsequent Forms 10-Q, under
the heading MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180925005664/en/
LabCorp:Investors:Scott Frommer,
336-436-5076Investor@labcorp.comorMedia:Pattie Kushner,
336-436-8263Media@labcorp.com
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Apr 2023 to Apr 2024